**United States Sales and Usage Limitation: For Research Use Only. Not for use in diagnostic procedures.

INTENDED USE

The Biotrin Human Herpesvirus-8 (HHV-8) IgG EIA is intended for the qualitative detection of Human Herpesvirus-8 IgG antibodies in human serum and plasma samples.

ASSAY PRINCIPLE

The Biotrin HHV-8 IgG Enzyme Immunoassay (EIA) is a direct EIA based on the binding of HHV-8-specific antibodies to lytic peptide antigens coupled to microtitre test strips.

The assay is a 96 well EIA, with each well of the plate coated with HHV 8 antigen. Patient sample are applied the wells and if HHV 8 IgG antibodies are present in the samples, they will bind with the HHV 8 antigen during an incubation step.

Following the 16 step assay procedure, the colour intenstity of the contents of each well is directly related to the concentration of the Human Herpes Virus-8 IgG antibodies in a patient sample.

 Rapidly & Easily identify if the patient has an active HHV 8 infection

 Excellent sensitivity and specificity

 Positive and Negative controls included

 Qualitative and Quantitative results

 96 well EIA – Break apart wells

Additional Information

HHV-8:  Questions & Answers

Download Product Instructions for Use (RUO)